Order Drugs Now

TEL: 1 866 893 0369
FAX: 1 866 402 4033

Pharma Industry News

Subscribe to Newsletter

To get info on the latest products, specials and pharmacy news, please enter your e-mail address:


August 7th, 2009
FDA Warns Consumers of Body Building Products Promoted as Dietary Supplements

The US FDA has advised healthcare practitioners and consumers of current safety information with regard to body building and increase muscle mass products, these products are commonly described as a substitute for anabolic steroids (used to increase muscle mass and strength), available both online and in retail establishments.

August 7th, 2009
Steam Dietary Supplement Pulled From Pharmacy Shelves

The FDA’s laboratory analysis discovered sulfoaildenafil, an analog of sildenafil. Sildenafil is a key ingredient in the FDA-approved drug for erectile dysfunction, which makes Steam an unsanctioned drug.

August 7th, 2009
Baxter Completes CELVAPAN A/H1N1 Pandemic Vaccine

Baxter International has recently announced that they have finished the production of their first commerical batches of CELVAPAN A/H1N1 pandemic vaccine. Currently, Baxter is discussing distribution options with national health authorities, so long as they receive appropriate permission. Baxter implemented their proprietary Vero cell production technology when developing CELVAPAN.

August 7th, 2009
FDA Demands TNF Blockers to Include Cancer Warnings

The US FDA requires TNF blockers to include firm detailed warnings in the prescribing information. The warnings, which also involves an up to date box warning, spotlights the increase chance of cancer in children and adolescents who first obtain the drug to treat juvenile rheumatoid arthritis, inflammatory bowel disease, Crohn's disease and other inflammatory diseases.

August 7th, 2009
FDA Warns: Clarcon Skin Products Present Health Threats

The US FDA cautions consumers of the harmful effects Clarcon skin products are having on the skin. They urge consumers to cease all usage of Clarcon Biological Chemistry Laboratory skin sanitizer or protectants, because of hazardous bacteria.

August 7th, 2009
Insmed Maintains Limited IPLEX Supply for Existing Patients

Biopharmaceutical company Insmed Inc. has publicized that effective immediately, they will halt new patient distribution of Iplex. They feel it is in the existing patients best interest to maintain supplies at this time for their treatment only. As a result, at this time, Insmed will not instigate further clinical trials of Iplex.

August 7th, 2009
US FDA Supports Once-Daily Diabetes Treatment Onglyza

Recently, the US FDA has approved a once-daily tablet to treat adult Type 2 Diabetes. Along with diet and exercise, Onglyza will assist to manage high blood sugar levels.

August 7th, 2009
US FDA Supports Antipsychotic Once-Monthly Invega Sustenna

The US FDA has recently approved Invega Sustenna extended-release injectable suspension for acute and maintenance therapy of adult schizophrenia. Invega Sustenna is the first US approved once a month injectable, long-acting, atypical antipsychotic.

August 7th, 2009
Nanoparticles Acts as New Drug Vehicle to Cancer Cells

US researchers report confidence in Nanoparticles ability to carry cancer-killing radioisotopes directly to tumors

August 7th, 2009
Ranbaxy Recalls Nitrofurantoin off U.S. Shelves

Recently, Ranbaxy Pharmaceuticals Inc. announced their voluntary recall of all Nitrofurantoin Capsules lot (USP 100 mg capsules), that currently exist on the U.S. marke


Search for Medication or Types of Conditions



: 0
Total: $0.00

view my cart check out credit cards

Find out how much you can save now!

download order form


Medicine Shoppe Pharmacy
148 #9 31205 Maclure Road
Abbotsford BC, Canada

Ph: 1-866-893-0369
Fax: 1-800-878-7930

Licence J30
Manager: S. Maan


TEL: 1 (866) 893-0369
FAX: 1 (800) 878-7930